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Abstract
Biodegradable porous scaffolds have been investigated as an alternative approach to current
metal, ceramic, and polymer bone graft substitutes for lost or damaged bone tissues. Although
there have been many studies investigating the effects of scaffold architecture on bone forma-
tion, many of these scaffolds were fabricated using conventional methods such as salt leaching
and phase separation, and were constructed without designed architecture. To study the effects
of both designed architecture and material on bone formation, this study designed and fabri-
cated three types of porous scaffold architecture from two biodegradable materials, poly (L-lactic
acid) (PLLA) and 50:50 Poly(lactic-co-glycolic acid) (PLGA), using image based design and indirect
solid freeform fabrication techniques, seeded them with bone morphogenetic protein-7 transduced
human gingival fibroblasts, and implanted them subcutaneously into mice for 4 and 8weeks. Micro-
computed tomography data confirmed that the fabricated porous scaffolds replicated the designed
architectures. Histological analysis revealed that the 50:50 PLGA scaffolds degraded but did not
maintain their architecture after 4weeks implantation. However, PLLA scaffolds maintained their
architecture at both time points and showed improved bone ingrowth, which followed the internal
architecture of the scaffolds. Mechanical properties of both PLLA and 50:50 PLGA scaffolds de-
creased but PLLA scaffolds maintained greater mechanical properties than 50:50 PLGA after implan-
tation. The increase of mineralized tissue helped support the mechanical properties of bone tissue
and scaffold constructs between 4–8weeks. The results indicate the importance of choice of scaffold
materials and computationally designed scaffolds to control tissue formation and mechanical prop-
erties for desired bone tissue regeneration. Copyright © 2011 John Wiley & Sons, Ltd.
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1. Introduction
Bone graft substitutes such as titanium and other
metals have been used for reconstructing bone defects
caused by injury, inflammatory disease, and cancer.
However, these implants are less than ideal because
the materials are non-degradable and can cause stress
shielding. Tissue-engineered scaffolds have been
studied as alternative implants to heal skeletal defects.
To enhance bone tissue integration and bone growth
into tissue-engineered scaffolds, scaffolds should have
a porous architecture to encourage cell migration and
blood vessel formation (Karageorgiou and Kaplan,
2005). It is also necessary that they have sufficient
mechanical properties to support physiologic loading
and proper degradation profiles to transfer loads to
regenerating tissues during healing (Athanasiou et al.,
1998; Hutmacher, 2001; Hollister, 2005).
Poly(L-lactic acid) (PLLA) and Poly(lactic-co-glycolic
acid) (PLGA) have both been approved by the FDA for
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specific clinical indications (Middleton and Tipton, 2000).
They have been successfully used as orthopaedic implants
(Athanasiou et al., 1998; Kontakis et al., 2007) and have
been widely studied as scaffolds for bone regeneration
both in vitro and in vivo. Due to different degrees of
hydrophilicity, degradation ratios, and by-products, PLLA
and PLGA have different effects on cell behaviour and tis-
sue regeneration, and have been compared in different
matrices including films, porous sponges, and fibre
like shapes using various cell types (Narayan and
Venkatraman, 2008; Li et al., 2006; Kaushiva et al.,
2007; Ishaug-Riley et al., 1999). It has been shown that
degradation time changes depending on the ratio of lactic
acid and glycolic acid polymer (Li et al., 2006; Kaushiva
et al., 2007; Lu et al., 2000). Therefore, adjusting the poly-
mer ratio should control the degradation time of these
scaffolds and their distinct degradation profiles could in-
fluence bone regeneration.
In addition to scaffold material composition, factors
influencing scaffold architecture such as porosity and
pore size play a critical role in cell migration and bone
formation into the scaffolds (Gomes et al., 2006; Khan
et al., 2008). It has been postulated that a~ 100-mm
pore diameter is suitable for in vitro cell migration
and a 300-mm pore diameter is necessary for tissue in-
growth and nutrient diffusion (Karageorgiou and
Kaplan, 2005; Cao et al., 2006). However, the effects
of scaffold architecture on bone tissue formation are
not fully understood and vary significantly between
studies (Schek et al., 2006; Li et al., 2007; Rose
et al., 2004; Tsuruga et al., 1997; Kuboki et al., 2001;
Ishaug-Riley et al., 1997; Ishaug-Riley et al., 1998; Wu
et al., 2006). Because the effects of scaffold architec-
ture on bone formation can differ depending on the
materials studied (Wu et al., 2006, Sinha et al., 1994)
and the ability to fabricate scaffolds with controlled
pore architectures (Melchels et al., 2010), it is neces-
sary to investigate the effects of rigorously controlled
architectures for each biodegradable scaffold to clearly
delineate architecture versus material influence on
bone regeneration.
Conventional biodegradable scaffolds, especially
scaffolds made from PLLA and PLGA, have been com-
monly fabricated by salt leaching or gas foaming and
have a wide range of pore sizes with poor or non-
interconnected pores, and the scaffold architectures
are not identically duplicated with repeated samples
(Hsu et al., 2007; Hutmacher et al., 2001). It is also
difficult to control local pore and wall locations and
porosities of these scaffolds. Currently, scaffold archi-
tecture is controlled at the global or overall scaffold
level. Furthermore, to ensure pore interconnectivity,
porosity needs to be increased and as a result, the
mechanical properties of scaffolds could thereby be
reduced (Goldstein et al., 1999).
To overcome these limitations, the combination of
computer aided design and solid freeform fabrication
techniques have been developed (Hollister, 2005; Sun
et al., 2004, Hutmacher et al., 2004, Martins et al.,
2009). These methods allow the design and fabrication
of scaffolds with controllable local pore architecture to
generate reproducible and effective mechanical and mass
transport properties. The current authors developed
image-based design techniques by which the internal
architectures of scaffolds could be customized based on
the mathematical concept of unit cells (Hollister et al.,
2000; Hollister et al., 2002; Lin et al., 2004). These unit
cells were designed and fabricated to have the desired
effective physical properties such as compressive modu-
lus, permeability, and diffusivity. Furthermore, the indi-
rect solid freeform fabrication (SFF) method was used
to fabricate scaffolds with designed pore diameters,
struts sizes, and porosities (Taboas et al., 2003). Using
these techniques, the authors successfully designed and
fabricated 50:50 PLGA porous scaffolds with compres-
sion moduli within the range of human trabecular bone
(Saito et al., 2010).
Bone morphogenetic proteins (BMPs) belong to the
TGF-b family and have been extensively applied using
direct BMP delivery or in vivo or ex vivo delivery via
gene therapy to induce bone formation for skeletal
regeneration (Bessa et al., 2008a; Bessa et al., 2008b;
Nussenbaum and Krebsbach, 2006). The current study
method selected to express BMPs in vivo used human
dermal and gingival fibroblasts that were transduced
by recombinant adenovirus encoding BMPs to induce
bone formation in ectopic sites (Rutherford et al.,
1992; Krebsbach et al., 2000). This technique was com-
bined with porous SFF scaffolds to facilitate bone gen-
eration (Schek et al., 2006; Williams et al., 2005; Lin
et al., 2005; Roosa et al., 2010). As a result, this
ex vivo gene therapy method was applied to induce
bone formation in the engineered scaffolds.
The goal of this study was to determine the influence of
scaffold material and architecture, especially pore size,
strut size, and surface/volume ratios on bone formation
in vivo, and to evaluate the mechanical properties of the
resulting scaffolds and tissue constructs. Six groups of
scaffolds (three different designs and two different mate-
rials; PLLA and 50:50 PLGA scaffolds) were fabricated.
The scaffolds were seeded with transduced human gingi-
val fibroblasts expressing BMP-7 and then implanted into
mice subcutaneous pockets for 4 and 8weeks. The
scaffolds and scaffold-regenerated bone tissue constructs
were evaluated using micro-computed tomography (m-CT),
mechanical testing, and histological assessments.
2. Methods
2.1. Porous scaffold design and fabrication
Porous scaffolds 5mm in diameter and 3mm high with
three different pore diameters (280, 550, and 820 mm)
were designed using image-based techniques (Figure 1a).
Based on the designed pore sizes, each group of scaffolds
was named large (pore size=820 mm), medium (pore
size=550 mm), or small (pore size=280 mm). First, the
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unit cells of each design were determined, and then
generated in a repeating pattern to fill the external scaffold
geometry. The resulting image representations were
converted to stereolithography (STL) formats and sliced
using Modelworks software (Solidscape Inc., Merrimack,
NH, USA) to fabricate wax molds using a ModelMaker II
for large and medium scaffolds and PatternMaster™
(Figure 1b) for small scaffolds 3D printer (Solidscape).
The wax molds (Figure 1c) were cast into hydroxyapatite
ceramic (HA) secondary molds (Figure 1d). Next, polymer
pellets PLLA (inherent viscosity=0.65dl/g) and 50:50
PLGA (inherent viscosity=0.61dl/g) (Birmingham Poly-
mers Inc., Birmingham, AL, USA) were heated at 205 C
and 170 C, respectively in a Teflon mold. The HA molds
were then placed into the Teflon mold containing molten
polymer to force the polymer through the open pore net-
work. The HA molds were then removed from the porous
polymer scaffolds using RDO Rapid Decalcifier (APEX En-
gineering Products Corp, Plainfield, IL, USA). The scaffolds
were then sterilized in 70% ethanol overnight and left in
100% ethanol until the day of implantation.
2.2. Cell preparation and scaffold implantation
Primary human gingival fibroblasts (HGFs) were prepared
from explants of human surgical waste in compliance
with the University of Michigan Institutional Review
Board (Rutherford et al., 1992). HGFs from passage 5–10
were cultured near confluence in Alpha minimum essen-
tial medium (a-MEM) supplemented with 10% foetal
bovine serum and 1% penicillin and streptomycin (GibcoW;
Invitrogen, Carlsbad, CA, USA). 24h before implantation,
the HGFs were infected with AdCMV-BMP7, a recombinant
adenovirus construct expressing murine BMP-7 gene,
under a cytomegalovirus (CMV) promoter at a multiplicity
of infection (MOI) of 1000 PFU/cell (Franceschi et al.,
2000). Two million cells were seeded into each scaffold
by suspending them in 60 ml of 5mg/ml bovine plasma-
derived fibrinogen (Sigma-Aldrich Corp., St-Louis, MO,
USA) and gelled with 6ml of 100 U/ml bovine plasma-
derived thrombin (Sigma). The scaffolds were subcutane-
ously implanted into immunocompromised NIH-bg-nu-xid
mice (Charles River, Wilmington, MA, USA). After the
Figure 1. Porous scaffolds were designed using image based design techniques and exported into STL formats (Large, Medium and
Small, from left to right) (a). The stl format files were imported to the rapid prototyping machines (b) to print the thermoplastic
molds (c). The thermoplastic molds were casted into HA secondary molds (d), and finally the HA secondary molds were casted into
either PLLA scaffolds (e) or 50:50 PLGA scaffolds (f)
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animals were anesthetized with an injection of ketamine/
xylazine, four subcutaneous pockets were created and four
scaffolds were implanted into each mouse, and finally,
surgical sites were closed with wound clips in compliance
with the University Committee on the Use and Care of
Animal (UCUCA) regulations. The mice were sacrificed at 4
and 8weeks after implantation and the scaffold and tissue
constructs were harvested, fixed with Z-fix (Anatech Ltd.,
Battle Creek, MI, USA), and left in 70% ethanol for further
assays.
2.3. Scaffold and regenerated tissue assays
All scaffolds (pre-implantation alone and post-implantation
with tissues) were scanned using a MS-130 high reso-
lution m-CT Scanner (GE Medical Systems, Toronto,
Canada) at a resolution of 16 mm. The scanned images were
reconstructed using MicroView software (GE). The
reconstructed images were used to calculate scaffold pore
size, porosity, and surface area prior to implantation, and
bone volume (BV) and tissue mineral density (TMD) were
calculated for the scaffolds after implantation. The surfaces
of pre-implanted scaffolds were also examined under a
Philips XL30 ESEM scanning electron microscope (Phillips,
Andover, MA, USA). The environmental scanning electron
microscopy (ESEM) mode was carried out at 10 kV and in
a humid atmosphere of 0.7Torr.
2.4. Mechanical test of scaffolds with
regenerated tissue
Following m-CT scanning, 4–7 replicates from each scaffold
group were mechanically tested. Compression tests were
performed after scaffolds were rehydrated for 30min using
a MTS alliance RT/30 electromechanical test frame (MTS
Systems Corp., Eden Prairie, MN, USA). The crosshead
speed was 1mm/min after a preload of 0.227 kg (0.5 lbs)
for PLLA scaffolds and 0.0227 kg (0.05 lbs) for 50:50 PLGA
scaffolds. The heights of the scaffolds weremeasuredwith a
caliper, and TestWorks 4W software (MTS Systems Corp.)
was used to record load and displacement data. The
stress-strain curves were calculated from the initial dimen-
sions of the specimens. The compressive modulus was
defined by the slope at the initial linear section of the
stress-strain curve.
2.5. Histological analysis
After m-CT scanning, one harvested scaffold from each
group was used for histological assay. The scaffold and
tissue constructs were demineralized with RDO and the
residual polymer in the tissue was removed using chloro-
form prior to paraffin embedding. The scaffolds were then
sectioned at 5mm and stained with hematoxylin and eosin
(H&E).
2.6. Statistical analysis
Statistical analysis was performed with SPSS (SPSS Inc.,
Chicago, IL, USA). Two groups were analyzed with
Student’s t-test for independent samples. Multiple com-
parison procedures were determined by One-Way ANOVA
followed by Tukey’s Post-Hoc multiple comparisons.
Errors were reported as the standard deviation (SD)
and significance was determined using a probability
value of p< 0.05.
3. Results
3.1. Evaluation of the fabricated (pre-implanted)
scaffolds
The schematics of the design and fabrication process of
the scaffolds are depicted in Figure 1. HA secondary
molds (Figure 1 d) ensured that the fabrication process
was identical between PLLA and 50:50 PLGA scaffolds,
except for polymer casting temperatures. The architec-
ture of the designs was the same for both fabricated
PLLA and 50:50 PLGA scaffolds (Figures 1e, 1f),
which was also confirmed by m-CT rendering images
(Figures 2a-f). The orthogonal pore locations and con-
nections of the fabricated PLLA and 50:50 PLGA
scaffolds were also confirmed from the cross-sectional
images of m-CT data (Figures 2g-l). Low magnification
ESEM images were similar in all groups (Figures
2m-r), while the high magnification images showed
slightly rougher surfaces on the PLLA scaffolds than
the 50:50 PLGA scaffolds (Figures 2s-x, indicated by
stars). Furthermore, porosity, surface to volume ratio,
pore size, and strut size were measured using the m-CT
images (Table 1). For each parameter, there was no
significant difference between the fabricated PLLA
and 50:50 PLGA scaffolds. These data support the
concept that the scaffold architectures within each de-
sign group (large, medium, small) made of the two
materials were identical to each other. Porosity, pore
size, and strut size of the fabricated scaffolds de-
creased in order from large to small pore designs.
The small group had a higher surface to volume ratio
than the large and medium groups for both PLLA and
50:50 PLGA scaffolds.
3.2. Histological observations of implanted
scaffolds
Due to the secretion of BMP-7 from the transduced
HGFs, all implanted scaffolds had bone-like tissue for-
mation after 4 and 8weeks (Figure 3). Histological
images of cortical bone-like tissues forming outer layers
and bone marrow-like tissues such as trabecular struc-
tures, endothelial cells, and osteoblasts were observed
within the cortical layer and the scaffolds. In the
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4-week implant groups, most of the marrow-like tissues
were distributed in the peripheral regions of the
specimen. However, more bone marrow-like tissues
containing blood vessel-like tissues were observed in
the 8-week than in 4-week implants. Marrow-like tissue
was found both at the centre of the scaffolds and in
the surrounding regions at 8weeks.
Histological images also show that tissue formation
differed between PLLA and 50:50 PLGA scaffold
groups. After 4 weeks implantation, little degrada-
tion of PLLA was observed and most of their architec-
tures remained intact (Figures 3a-c). However, 50:50
PLGA scaffolds degraded much rapidly and lost
their initial architectures (Figures 3d-f). After 8weeks
implantation, PLLA scaffolds maintained their architec-
ture, while most of 50:50 PLGA degraded, leaving very
little polymer, and the bone constructs appeared flat-
tened (Figures 3h-m). After degradation of most of
the 50:50 PLGA scaffolds, histological images showed
more bone marrow-like tissues containing blood
vessel-like tissues in the 8-week compared to the
4-week implants. For PLLA scaffolds, bone-like tissues
formed mostly in the peripheral area of the scaffolds
and very little bone ingrowth was observed (Figures
3a-c and 3g), and a few blood vessel-like tissues were
seen inside of the scaffolds (Figure 3g) at 4weeks. At
8weeks, advanced bone ingrowth was observed
following the porous architectures of the small PLLA
scaffolds (Figure 3j), and larger blood vessel tissues
were also observed (Figure 3n). In addition, there
might have been more fibrous tissue on PLLA scaffolds
at week 4 than week 8.
3.3. Tissue observations using m-CT
3D tissue representations were generated from m-CT data
(Figure 4). Mineralized tissues were highlighted and col-
our contours indicated the density of the regenerated tis-
sues. Highly dense tissues were distributed only on the
Figure 2. m-CT rendering images (a-f),m-CT images showing cross sectional x, y, and z planes (g-l), and ESEM images of fabricated PLLA
and 50:50 PLGA scaffolds (m-x). The scale bars in the ESEM images are 1mm and 200mm for Low (m-r) and High magnifications (s-x),
respectively. * indicates the surface around the pores for comparison of the surface morphologies of PLLA and 50:50 PLGA scaffolds
Table 1. Fabricated scaffold dimensions
PLLA 50:50 PLGA
Large Medium Small Large Medium Small
Pore size (mm) 0.8210.041 0.5800.039 0.2850.026 0.8400.057 0.5370.033 0.2580.037
Strut size (mm) 0.9140.028 0.5940.033 0.4130.017 0.8980.045 0.6220.050 0.4480.039
Porosity (%) 52.10.95 45.43.21 32.13.50 52.92.17 43.82.21 30.53.30
Surface/Volume (mm2/mm3) 4.570.22 4.540.15 5.400.17 4.650.25 4.880.31 5.430.59
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outside of the scaffolds. Due to rapid degradation, there
was no bone growth into the 50:50 PLGA scaffolds. All
PLLA scaffolds maintained their architecture at all time
points. There was some bone ingrowth into the PLLA
scaffolds at 4weeks, while there was slightly more
bone ingrowth at 8weeks. Maximum bone penetration
was measured as the distance from the circular periph-
eral edge of each scaffold towards the centre (N=3–5
scaffolds). Bone penetration in the small, medium,
and large PLLA scaffolds was 0.464 0.024mm,
0.723 0.392mm, and 0.457 0.146mm, respectively
at 4weeks, and 1.043 0.292mm, 0.834 0.249mm,
and 0.773 0.049mm, respectively at 8weeks. Small
PLLA scaffolds supported a significant increase of bone
penetration between weeks 4 and 8. Large and medium
PLLA scaffolds also had increases in bone penetration
but these did not reach a statistically significant level.
There was no significant difference between the
scaffold groups at each time point. In addition, the pat-
tern of bone ingrowth followed the internal scaffold
architectures and bone tissues regenerated along the
struts (Figures 4g-i). More bone tissue distribution
was observed at 8weeks than at 4weeks, with the
highest amounts seen in the small PLLA group, which
had more bone surrounding the struts (Figure 4i).
3.4. Tissue mineral density and bone volume of
implanted scaffolds
TMD and BV were also calculated using m-CT data
(Figure 5, Table 2). The data demonstrated that TMD sig-
nificantly increased in all groups between 4- and 8-week
implantation. From the 4-week implantation data,
although there was no significant difference, the small
PLLA scaffold group had higher TMD than the large and
Figure 3. Histological images of PLLA (a, b, and c) and 50:50 PLGA scaffolds (d, e, and f) at 4weeks and PLLA (h, i and j) and 50:50
PLGA scaffolds (k, l, and m) at 8weeks. Porous architectures of PLLA scaffolds were maintained for all groups (a, b, and c) at 4weeks
and (h, i, and j) at 8weeks. None of 50:50 PLGA groups maintained the initial architectures, however, polymer material was still left
inside of the bony shells at 4weeks (d, e, and f). After 8weeks, most of 50:50 PLGA polymer had degraded and disappeared (k, l, and
m). Magnified areas of Small PLLA scaffold at 4weeks (c) were shown (h: dashed-dotted line). Yellow arrow indicates fibrous tissue
between scaffold and trabecular like tissue, and a few blood vessel-like tissues were indicated by blue arrows (g). Magnified areas of
Small PLLA scaffold at 8weeks (j) were also shown (n: dashed-dotted line). Thicker blood vessel-like tissues were observed within the
scaffold pores, shown by blue arrows (n)
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medium PLLA scaffold groups (Figure 5a). In addition,
the large and medium 50:50 PLGA scaffold groups
had more mineralized tissues than the large and medium
PLLA scaffold groups at 4weeks (no significant differ-
ence). Medium and small PLLA scaffold groups showed
slightly higher mineral density than medium and small
50:50 PLGA scaffold groups (Figure 5b). The results of
TMD were similar in all groups at both time points, while
BV results showed different trends depending on the
scaffold materials. Although only the large 50:50 PLGA
showed a significant difference (Figures 5c-5d), the
trends suggested that PLLA scaffolds lost their BV be-
tween the 4- and 8-week time points, while 50:50 PLGA in-
creased BV during that time. In addition, other trends
showed that PLLA scaffolds had more BV than 50:50 PLGA
scaffolds at the 4-week time point (Figure 5c). However,
after 8weeks implantation, 50:50 PLGA scaffolds showed
higher BV (Figure 5 d) (no significant difference).
3.5. Mechanical properties
A compressive test was performed to investigate the
changes in scaffold mechanical properties during im-
plantation (Figures 6a, 6d). The average mechanical
properties of PLLA and 50:50 PLGA scaffolds were≥
100MPa prior to implantation. All PLLA scaffolds had
significantly decreased mechanical properties after
4weeks implantation due to polymer degradation
(Figure 6a). Then, their mechanical properties were in-
creased or maintained after 8weeks implantation due
to growth of mineralized tissues. All 50:50 PLGA
scaffolds had a nearly complete loss of mechanical
properties at 4weeks but then slightly increased after
8weeks implantation (Figure 6b). The mechanical
properties of all 50:50 PLGA scaffolds were signifi-
cantly lower than small PLLA scaffolds at 4weeks and
medium and small PLLA scaffolds at 8weeks.
The correlation between the modulus and bone
volume are shown in Figures 6b, 6c, 6e, and 6f. PLLA
scaffolds did not have any correlation at 4 (R2=0.0371)
and 8 (R2=0.0102) weeks. However, 50:50 PLGA scaffolds
had some correlation at 4 (R2=0.4809) and 8 (R2=0.4043)
weeks. The 8-week data had an outlier that lowered
the correlation, which increased to R2=0.8884 without
the outlier. These results indicate that increased bone
deposition increased the moduli of the regenerated tissues
when the scaffold modulus was significantly reduced.
4. Discussion
In this study, computer based scaffold design and SFF
were used to determine the effects of porous scaffold
Figure 4. m-CT images of PLLA (a, b, and c) and 50:50 PLGA scaffolds (d, e, and f) at 4weeks, and PLLA (g, h, and i) and 50:50 PLGA
scaffolds (j, k, and l) at 8weeks. Some struts were surrounded by tissues are indicated by *. Relative density of the tissues are indi-
cated with color scale (m)
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material and architecture on bone regeneration. PLLA
and 50:50 PLGA scaffolds were fabricated using identi-
cal procedures with the exception of their melting
temperatures. The semi-crystalline structure of PLLA
required a higher casting temperature, while the
50:50 PLGA was melted at a lower temperature than
PLLA due to its amorphous structure. m-CT data dem-
onstrated that the fabricated PLLA and 50:50 PLGA
scaffolds had similarly-defined pore sizes, strut sizes, po-
rosities, and surface to volume ratios. In addition, m-CT
results showed that the fabricated scaffolds in the same
design groups had identical internal and external archi-
tectures between materials. Although the viscosities of
the polymers were similar, the surface morphologies of
the scaffolds were slightly different, as shown in the ESEM
images. This could be due to the difference of the chemical
structures including crystallinity of the polymers.
Ex vivo gene therapy was used to induce bone forma-
tion from the surrounding tissues at the implant site.
This regenerative gene therapy strategy using adenoviral
vectors could be applied to transduce various cells such
as bone marrow stromal cells (Chang et al., 2003) and
fibroblasts (Krebsbach et al., 2000; Hirata et al., 2003).
The consistent secretion of BMP-2 from adenovirus
transduced HGFs for up to 2weeks in vitro has been
reported (Shin et al., 2010). Additionally, this approach
has been studied to induce endochondral-like bone tissue
formation by transduced HGFs (Krebsbach et al., 2000;
Figure 5. Tissue mineral density (TMD) at 4 (a) and 8 (b)weeks, and Bone volume (BV) at 4 (c) and 8 (d)weeks. There was no sig-
nificant difference of TMD and BV values between PLLA and 50:50 PLGA scaffolds
Table 2. Tissue mineral density, bone volume and modulus of scaffold and tissue constructs at 4 and 8weeks
PLLA 50:50 PLGA
Large Medium Small Large Medium Small
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Rutherford et al., 2002). Other methods of bone forma-
tion have previously been reported, including seeding
bone marrow stromal cells (Claase et al., 2007), incor-
poration of BMP-7 into nanospheres (Wei et al., 2007),
and BMP-2 conjugated with heparin (Claase et al., 2007).
However, these methods require pre-treatment of the
scaffolds prior to implantation. The scaffolds could start
degrading during the preparation, especially 50:50 PLGA
scaffolds, due to their short degradation profile. Therefore,
to minimize any alteration of the scaffolds before implanta-
tion and to successfully regenerate bone tissue in vivo,
ex vivo gene therapy was used as a suitable method for
testing in this current study.
Scaffold tissue constructs differed between the PLLA
and 50:50 PLGA scaffolds due to polymer degradation.
PLLA scaffolds maintained their architecture through-
out the study period, while 50:50 PLGA scaffolds
completely lost the original designed pore structure,
and there were only chunks remaining at the 4-week
time point. The hydrophilicity of the PGA component
in PLGA could have induced faster water uptake and
hydrolysis, leading to faster degradation (Lu et al.,
2000). In contrast, the methyl group of the PLLA side
chain contributed to the hydrophobicity of the polymer,
resulting in slower degradation (Ishaug-Riley et al.,
1999). As reported previously, the in vivo half-life of
50:50 PLGA foams is about 2weeks (Lu et al., 2000).
The 50:50 PLGA scaffolds in the current study main-
tained their architectures for only a few weeks or less
in vivo.
Due to the rapid degradation, little bone tissue was
found inside the degraded 50:50 PLGA scaffolds at 4
and 8weeks. In contrast, the PLLA scaffolds had small
amounts of bone ingrowth and some blood vessel-like
tissues from the histological analysis. These differences
could be attributed to the effects of degradation of
by-products on cell activities. PLLA nanofibers or porous
membranes supported activities of chondrocytes and
human mesenchymal stem cells and vascularization
more than those of 50:50 PLGA, since rapid degrada-
tion of 50:50 PLGA created acidic environments and
prevented cell activities on or in the constructs (Li
et al., 2006, Kaushiva et al., 2007). In addition, reduc-
tion of pH negatively affected activities of bone marrow
stromal cells during osteogenesis (Kohn et al., 2002).
Although there are no data regarding pH change or
acidic by-products in the current study, there could be
similar effects on cell activities and tissue formation
for both PLLA and 50:50 PLGA scaffolds at the earlier
time point. Additionally, the collapse of the PLGA po-
rous architecture could inhibit cell migration and bone
formation within the scaffold interior.
The trends in BV results show that BV was greater on
the PLLA scaffolds than the 50:50 PLGA scaffolds at
4weeks, while the 50:50 PLGA scaffolds had greater BV
at 8weeks. The acidic environment could also explain
the change in bone volume over time. Initially, at 4weeks,
bone formation was inhibited by more acidic by-products
in the environment of the PLGA scaffolds, but the removal
of these degradation by-products allowed restoration of
Figure 6. Mechanical test results of implanted PLLA (a) and 50:50 PLGA (d). * indicates significant difference. Correlations between
modulus and bone volume of PLLA scaffolds at 4 (b) and 8 (c)weeks and 50:50 PLGA scaffolds at 4 (e) and 8 (f)weeks. R-square
values are 0.0371 (b), 0.0102 (c), 0.4809 (e) and 0.4043 (f). The value of (f) increases to 0.8884 without the outlier (indicated with
an arrow)
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cellular activities, which could have led to the bone
volume increase observed at the 8-week time point. The
PLLA scaffolds could have had more degradation by-
products, which would have lowered BV at 8weeks. From
the data shown in this and previous studies (Li et al.,
2006: Kaushiva et al., 2007; Kohn et al., 2002), PLLA
scaffolds could be more useful in this situation because
they have a slower degradation rate that allows new
tissue to generate while still maintaining sufficient me-
chanical properties to support new tissue growth. In com-
parison, 50:50 PLGA was not able to support the tissue
due to its fast degradation profile. It would be useful to
study another polymer such as 85:15 PLGA as a SFF
scaffold for bone application since it lasts longer in vivo,.
Furthermore, the effects of SFF scaffolds on degradation
need to be further investigated to better understand the
interaction between scaffolds and tissue formation.
The PLLA scaffolds in this study showed much less
bone ingrowth than porous HA scaffolds and porous
poly (propylene fumerate)/tricalcium phosphate (PPF/
TCP) scaffolds reported in previous studies (Schek
et al., 2006; Lin et al., 2005), since HA and TCP are
known osteoconductive materials that have been
shown to allow chemotactic adherence for enhanced
bone growth. Furthermore, hydrophobic materials like
PLLA could delay cell attachment and bone formation
(Oh et al., 2007, Oh et al., 2003). In addition, the
layers of tissues or bony shell surrounding the PLLA
scaffolds prevented diffusion of nutrients into the con-
struct (Kruyt et al., 2007) and could cause accumula-
tion of acidic by-product inside the implants, which
would inhibit cell migration and tissue ingrowth.
The importance of scaffold pore sizes for bone forma-
tion has been extensively studied. The 280 mm minimum
pore size used in the current study was chosen based on
the required diameters for blood vessel formation, which
were approximated according to in vivo bone tissue forma-
tion in previous studies (Kuboki et al., 2001; Oh et al.,
2007; Druecke et al., 2004). Although the effect of pore
size of PLLA or PLGA porous scaffolds on bone regenera-
tion has been explored in various studies, results have
varied depending on the materials and methods used.
For example, pore sizes of PLGA scaffolds did not affect
osteoblast activities in vitro nor was in vivo bone
formation influenced by pore sizes within the range of
150–710mm and 125–500 mm (Ishaug-Riley et al., 1997;
Ishaug-Riley et al., 1998; Wu et al., 2006). In contrast,
other studies compared porous PLGA scaffolds with
constant porosity and indicated that pore sizes of
400–600 mm were favourable for osteoblasts rather than
300 mm or smaller pore sizes (Pamula et al., 2008a;
Pamula et al., 2008b). Another study demonstrated that
PLLA scaffolds with pores of 350 mm diameters induced
more bone ingrowth than the smaller ones (100 and
200 mm) when implanted in rabbit calvarias (Robinson
et al., 1995). However, it is again important to note that
these previous studies, which suggested an influence of
pore diameter (Pamula et al., 2008a; Pamula et al., 2008b;
Robinson et al., 1995), used conventional fabrication
techniques that did not rigorously control pore diameter
and interconnectivity. The current study’s chosen pore sizes
of 280, 550, and 820mm therefore bracketed the range of
pore sizes investigated in previous studies; with the differ-
ence being the controlled, interconnected, and repeatable ar-
chitecture used in the current study. The pore range was also
within the range of reported trabecular pore sizes of
300~1000mm (Keaveny et al., 2001; Rezwan et al., 2006).
Regarding bone ingrowth from m-CT images, this
study did not observe any significant differences be-
tween the scaffolds designs such as pore size, which
is in agreement with previous studies (Schek et al.,
2006; Roosa et al., 2010). The distances of bone pene-
tration into the PLLA scaffolds in this study was greater
than previously reported in PLGA foams implanted in
the rat mesentery for 49 days (Ishaug-Riley et al.,
1997). The distances generally increased between
4–8weeks in the current study, while the previous
study showed that there was little increase over
implantation time. This could be due to their use of
foam scaffolds, which have random oriented pores
and non-controlled internal architectures, and a more
tortuous pathway that could have prevented nutrient
diffusion and cell migration into the scaffolds
(Melchels et al., 2010). Silva et al. (2006) showed that
porous HA and PLLA scaffolds with aligned channels
could improve cell infiltration into the centre of the
scaffolds. Their study and the results of the current
study indicate that orthogonally interconnected porous
architectures might not only help increase nutrient dif-
fusion when compared to foam scaffolds, but could
also guide tissue ingrowth.
Other scaffold design parameters such as porosity
and surface area did not seem to have a significant
effect on bone formation in this current study.
Although high porosity has been discussed as an impor-
tant requirement of scaffolds (Sosnowski et al., 2006),
the effect of scaffold porosity on bone formation was
not significant in this study. Since the scaffolds used
in the current study had fully and orthogonally-
interconnected pore architectures or channels, infiltra-
tion of nutrients into the scaffolds might not have been
different between the scaffold design groups. The pore
sizes of the scaffolds varied the surface areas of the
scaffolds onto which cells from host tissues could
attach. m-CT data also showed that the patterns of
bone ingrowth followed the internal architectures of
the scaffolds. Small PLLA scaffolds had the smallest
strut and pore sizes, which allowed the tissues to
surround the struts and interlock, thereby increasing
tissue integration. This might have helped to form
stronger bonds between the regenerated tissues and
porous scaffolds. The scaffolds with smaller pores had
more total surface area than the scaffolds with larger
pores, which might have created a larger surface area
for cell adhesion and helped bone formation. Further-
more, another scaffold design parameter could have a
greater impact on increasing bone formation. For exam-
ple, it has been postulated that pore interconnectivity
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and permeability can be an important scaffold design
parameter (Melchels et al., 2010; Hui et al., 1996; Jones
et al., 2009).
For functional use of scaffolds at load bearing sites,
it is important to understand the time dependent
changes in scaffold/tissue construct mechanical proper-
ties. Initially, the fabricated PLLA and 50:50 PLGA scaf-
folds had mechanical properties in the low to medium
range of human trabecular bone (Saito et al., 2010).
After implantation, the mechanical properties de-
creased due to the degradation of materials. As shown
in the histology and m-CT images, 50:50 PLGA scaffolds
completely lost their designed architectures, and their
mechanical properties decreased dramatically at both
4 and 8weeks compared with the pre-implanted
scaffolds and PLLA scaffolds. Despite the retention of
designed architecture, PLLA scaffolds also showed a
decrease in their mechanical properties, which indi-
cated some polymer degradation.
The mechanical properties of PLLA scaffolds with
bone tissue were significantly higher than those of
50:50 PLGA scaffolds at 4 and 8weeks. There was no
correlation between bone volume and PLLA/bone
construct mechanical properties at 4 and 8weeks.
However, the 50:50 PLGA/bone construct mechanical
properties showed some correlation with bone volume
at 4weeks, which increased at 8weeks. The mechanical
properties of the PLLA scaffold constructs, due to the
greater retention of polymer architecture and mechanical
properties, were likely more dependent on the polymer at
4 and 8weeks. In contrast, the 50:50 PLGA mechanical
properties were solely dependent on the generated bone
as the polymer was degraded at 4 weeks.
Although the majority of PLLA mechanical properties
relied on the scaffold material, large and medium PLLA
scaffolds still exhibited an increasing trend in mechanical
properties due to higher mineralized tissues and bone
growth on the scaffolds between 4–8weeks. Small PLLA
scaffolds had similar mechanical properties at both time
points. Small PLLA scaffolds might have had a slower deg-
radation speed, thereby maintaining their mechanical
properties longer than the other groups.
One of the limitations of this study is that ectopic sites
did not provide the same environment as orthotopic sites,
including mechanical stimulation, nutrients, cell types,
and cell-cell interactions. For example, the bone volume
of PLLA scaffolds decreased between weeks 4 and 8,
similar to findings by Lin et al. (Lin et al., 2005). This
could be because there was little loading on the ectopic
models to simulate bone remodeling and increases in
mineralization of newly formed tissues (Duty et al.,
2007) and less nutrient supply. In addition, mechanical
loading on the scaffolds would have increased the degra-
dation of PLLA scaffolds in terms of molecular weight and
mechanical properties (Kang et al., 2009).
5. Conclusions
This study compared the effects of material and archi-
tectures of porous scaffolds on bone formation. Results
showed that material choice significantly influenced
in vivo bone tissue regeneration and mechanical prop-
erties. It was also observed that scaffold architecture
controls the patterns of bone ingrowth and mechanical
properties of scaffold-bone constructs. The 50:50 PLGA
scaffolds degraded rapidly, providing little initial sup-
port for bone ingrowth, and had very low mechanical
properties. In comparison, the PLLA scaffolds main-
tained their architecture throughout the study period
and supported some blood vessel and bone ingrowth.
Given the long tissue regeneration time observed in
many clinical applications (e.g., spine fusion, long bone
defects, mandibular defects), the ability of a polymer
scaffold to maintain structural and mechanical proper-
ties up to 6months is critical. Pore size, when architec-
ture is maintained and does not collapse, does not
significantly influence bone regeneration. The patterns
of bone tissue ingrowth were defined by the computer
designed pores and struts of the scaffolds. Furthermore,
mechanical properties of implanted scaffolds were con-
trolled by the initial architectures. These results support
the importance of choosing suitable scaffold materials
and designing conductive scaffold architectures that are
ideal for bone tissue regeneration. Each of these factors
needs to be fine-tuned to find the desired properties for
specific anatomical sites or defects.
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